GNL1

GNL1 is a nucleolar GTPase that couples cell-cycle-regulated nucleocytoplasmic shuttling to control of proliferation and cell survival (PMID:22244851, PMID:30061673). An N-terminal arginine/lysine-rich nucleolar localization signal directs GNL1 to the nucleus and nucleolus specifically in G2 phase through an importin-α/β-independent pathway, while a distinct region (amino acids 201–225) mediates CRM1-independent nuclear export, returning the protein to the cytoplasm in G1 and S; nucleolar retention is gated by GTP binding via the G2 motif of the G-domain, and disrupting this gating abolishes both nucleolar localization and GNL1-driven G2/M transition (PMID:22244851). In the nucleolus GNL1 binds the ribosomal protein RPS20 and drives Rb hyperphosphorylation to promote proliferation, an effect lost when RPS20 is depleted or when an interaction-deficient GNL1 mutant is used (PMID:30061673). GNL1 additionally suppresses apoptosis by modulating Bcl2-family proteins and blocking caspase-7/8 cleavage, and stabilizes cytoplasmic p21 through AKT-mediated phosphorylation, with its pro-survival activity dependent on p21 (PMID:33147101). GNL1 also binds G-quadruplex structures in the 5′UTRs of PRKN and VPS35 transcripts, identifying it as a G-quadruplex RNA-binding protein (PMID:33305682).

1. 2012 High

   Established how GNL1 traffics within the cell and that its localization is mechanistically tied to cell-cycle progression, defining it as a GTP-gated nucleolar shuttling GTPase that promotes G2/M transition.

   Evidence GFP-fusion microscopy with cell-cycle synchronization, alanine-scanning G-domain mutagenesis, heterokaryon shuttling, importin and CRM1 exclusion assays

   PMID:22244851

   Open questions at the time

   • Direct GTPase enzymatic kinetics not measured
   • The export receptor mediating CRM1-independent export is unidentified
   • Nucleolar substrates/effectors downstream of G2/M promotion not defined in this study
2. 2018 High

   Connected GNL1's proliferative function to a physical partner and a downstream cell-cycle target, showing it acts through RPS20 to drive Rb hyperphosphorylation.

   Evidence Yeast two-hybrid screen, GST pull-down, reciprocal co-IP, RPS20 knockdown and interaction-deficient mutant in proliferation and Rb phosphorylation assays

   PMID:30061673

   Open questions at the time

   • The kinase mediating Rb hyperphosphorylation downstream of GNL1–RPS20 is unidentified
   • Whether the interaction occurs in the nucleolus is not established
   • Direct biochemical contact surface not mapped
3. 2020 Medium

   Defined GNL1 as an anti-apoptotic factor that promotes survival via Bcl2-family modulation and AKT-dependent cytoplasmic stabilization of p21.

   Evidence GNL1 overexpression/knockdown with caspase and Bcl2 immunoblots, subcellular fractionation, AKT inhibitor, p53 and p21 knockdown epistasis in cancer cells

   PMID:33147101

   Open questions at the time

   • Whether GNL1 acts directly or indirectly on AKT/p21 is unresolved
   • Mechanism of p53 upregulation not defined
   • Single-lab functional study without orthogonal in vivo confirmation
4. 2020 Medium

   Identified an RNA-binding activity for GNL1, showing it recognizes G-quadruplex structures in disease-associated transcript 5′UTRs.

   Evidence Label-free G4 RNA affinity purification with wild-type versus mutant G4 bait from PRKN and VPS35 5′UTRs

   PMID:33305682

   Open questions at the time

   • Single pulldown-based identification without reciprocal validation or GNL1 mutagenesis
   • Functional consequence of G4 binding on transcript translation/stability not tested
   • Whether this activity links to its nucleolar GTPase role is unknown

• How GNL1's GTPase cycle, RPS20-dependent proliferative signaling, anti-apoptotic p21/AKT axis, and G-quadruplex RNA binding integrate into a single coherent mechanism remains unresolved.
• No unifying model linking nucleolar GTPase activity to RNA binding
• No structural data for GNL1 or its complexes
• Physiological GTPase substrate/regulators unidentified